secwatch.observer — SEC 8-K summary
======================================

Issuer:     COGNITION THERAPEUTICS INC (CGTX)
CIK:        0001455365
Form:       8-K
Filed at:   2024-03-11T23:59:59+00:00
Accession:  0001104659-24-032979
Event type: earnings
Sentiment:  negative
Materiality: 0.60
Item codes: 2.02
LLM model:  deepseek-v4-flash:cloud@v2

Cognition Therapeutics reports preliminary FY2023 net loss of $25.6M; cash at $29.9M
--------------------------------------------------------------------------------

- Preliminary net loss for FY2023 expected to be approximately $25.6 million.
- Cash and cash equivalents as of Dec 31, 2023: $29.9 million.
- Results are unaudited and subject to revision upon completion of audit.
- No revenue reported; company is a clinical-stage biotech.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1455365/000110465924032979/0001104659-24-032979-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1455365/000110465924032979/tm248362d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-032979

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer